| Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ... Nature cancer 1 (5), 493-506, 2020 | 264 | 2020 |
| Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma S Manier, J Park, M Capelletti, M Bustoros, SS Freeman, G Ha, J Rhoades, ... Nature communications 9 (1), 1691, 2018 | 181 | 2018 |
| Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression M Bustoros, R Sklavenitis-Pistofidis, J Park, R Redd, B Zhitomirsky, ... Journal of Clinical Oncology 38 (21), 2380, 2020 | 146 | 2020 |
| Genomic landscape of Waldenström macroglobulinemia and its impact on treatment strategies SP Treon, L Xu, ML Guerrera, C Jimenez, ZR Hunter, X Liu, M Demos, ... Journal of Clinical Oncology 38 (11), 1198, 2020 | 144 | 2020 |
| Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant TH Mouhieddine, AS Sperling, R Redd, J Park, M Leventhal, CJ Gibson, ... Nature communications 11 (1), 2996, 2020 | 118 | 2020 |
| Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression Y Kawano, O Zavidij, J Park, M Moschetta, K Kokubun, TH Mouhieddine, ... The Journal of clinical investigation 128 (6), 2487-2499, 2018 | 97 | 2018 |
| Genome instability in multiple myeloma CJ Neuse, OC Lomas, C Schliemann, YJ Shen, S Manier, M Bustoros, ... Leukemia 34 (11), 2887-2897, 2020 | 91 | 2020 |
| Progression risk stratification of asymptomatic Waldenström macroglobulinemia M Bustoros, R Sklavenitis-Pistofidis, P Kapoor, CJ Liu, E Kastritis, ... Journal of Clinical Oncology 37 (16), 1403, 2019 | 84 | 2019 |
| Patient-specific screening using high-grade glioma explants to determine potential radiosensitization by a TGF-β small molecule inhibitor NS Bayin, L Ma, C Thomas, R Baitalmal, A Sure, K Fansiwala, M Bustoros, ... Neoplasia 18 (12), 795-805, 2016 | 47 | 2016 |
| Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reports V Tyagi, J Theobald, J Barger, M Bustoros, NS Bayin, AS Modrek, ... Surgical neurology international 7, 2016 | 43 | 2016 |
| Established and novel prognostic biomarkers in multiple myeloma M Bustoros, TH Mouhieddine, A Detappe, IM Ghobrial American Society of Clinical Oncology Educational Book 37, 548-560, 2017 | 42 | 2017 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... The Lancet Haematology 9 (5), e340-e349, 2022 | 37 | 2022 |
| Minimal residual disease in myeloma: application for clinical care and new drug registration KC Anderson, D Auclair, SJ Adam, A Agarwal, M Anderson, ... Clinical Cancer Research 27 (19), 5195-5212, 2021 | 37 | 2021 |
| Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients R Sklavenitis-Pistofidis, M Capelletti, CJ Liu, M Reidy, O Zavidij, D Huynh, ... Blood, The Journal of the American Society of Hematology 132 (24), 2608-2612, 2018 | 35 | 2018 |
| Phase II trial of combination of elotuzumab, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma C Liu, IM Ghobrial, M Bustoros, K Reyes, K Hornburg, AZ Badros, ... Blood 132 (Supplement 1), 154-154, 2018 | 33 | 2018 |
| Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia J How, O Leiva, T Bogue, GG Fell, MW Bustoros, NT Connell, JM Connors, ... Leukemia research 98, 106459, 2020 | 29 | 2020 |
| Advancements in nanomedicine for multiple myeloma A Detappe, M Bustoros, TH Mouhieddine, PP Ghoroghchian Trends in Molecular Medicine 24 (6), 560-574, 2018 | 26 | 2018 |
| Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma M Bustoros, C Liu, K Reyes, K Hornburg, K Guimond, R Styles, A Savell, ... Blood 132, 804, 2018 | 25 | 2018 |
| A rare case of composite dural extranodal marginal zone lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma M Bustoros, B Liechty, D Zagzag, C Liu, T Shepherd, D Gruber, ... Frontiers in neurology 9, 267, 2018 | 24 | 2018 |
| Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma R Sklavenitis-Pistofidis, MP Aranha, RA Redd, J Baginska, ... Cancer Cell 40 (11), 1358-1373. e8, 2022 | 21 | 2022 |
